Approval · Notice of Compliance 30775 · 2023
HULIO: Notice of Compliance 30775
Issued May 15, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30775
- Date
- May 15, 2023
- Company
- Biosimilar Collaborations Ireland LimitedDublin, Ireland
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative ¿ Change in Product Ownership
- Canadian reference product
- HUMIRA
Products in this notice
Medicinal ingredients
- ADALIMUMAB 20 MG per SYR
- ADALIMUMAB 40 MG per SYR
- ADALIMUMAB 40 MG per PEN